Concepedia

Katsuya Nakai

KN

16

Publications

1.1K

Citations

13

H-Index

2011

Active since

Affiliations

Juntendo University(Current)

The University of Texas MD Anderson Cancer Center

Asia University

China Medical University

Fukushima Medical University

Katsuya Nakai is an author at Juntendo University specializing in medicine, breast cancer, and oncology.

ORCID

Top concepts

Publications per year

2011–2022

16

Publications

16

A perspective on anti-EGFR therapies targeting triple-negative breast cancer.

Katsuya Nakai, Mien‐Chie Hung, Hirohito Yamaguchi · PubMed · 2016 · 327 citations · Full text

, , +12

Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors

Yi Du, Hirohito Yamaguchi, Yongkun Wei et al. · Nature Medicine · 2016 · 240 citations · Full text

, , +7

EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer

Hirohiko YAMAGUCHI, Yi Du, Katsuya Nakai et al. · Oncogene · 2017 · 114 citations · Full text

, , +9

Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer

Pei‐Chih Lee, Yueh‐Fu Fang, Hirohito Yamaguchi et al. · Cancer Cell · 2018 · 71 citations · Full text

, , +8

Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study

Yoshiya Horimoto, Emi Tokuda, Fumi Murakami et al. · Journal of Translational Medicine · 2018 · 69 citations · Full text

Rows per page

1–5 of 16